User profiles for Milan Grkovski

Milan Grkovski

Assistant Attending Physicist, Memorial Sloan Kettering Cancer Center
Verified email at mskcc.org
Cited by 791

Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial

…, X Pei, H Schöder, M Grkovski… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Patients with human papillomavirus–related oropharyngeal cancers have
excellent outcomes but experience clinically significant toxicities when treated with standard …

[HTML][HTML] B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors …

S Modak, P Zanzonico, M Grkovski… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE Desmoplastic small round cell tumor (DSRCT), a rare sarcoma of adolescents/young
adults primarily involving the peritoneum, has a long-term survival of< 20% despite …

Safety and Feasibility of PARP1/2 Imaging with 18F-PARPi in Patients with Head and Neck Cancer

…, E Burnazi, S Roberts, C Brand, M Grkovski… - Clinical Cancer …, 2020 - AACR
Purpose: We performed a first-in-human clinical trial. The aim of this study was to determine
safety and feasibility of PET imaging with 18 F-PARPi in patients with head and neck cancer. …

Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics …

M Crispin-Ortuzar, A Apte, M Grkovski, JH Oh… - Radiotherapy and …, 2018 - Elsevier
Background and purpose Hypoxia is a known prognostic factor in head and neck cancer.
Hypoxia imaging PET radiotracers such as 18 F-FMISO are promising but not widely available. …

Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics

MR Folkert, J Setton, AP Apte, M Grkovski… - Physics in Medicine …, 2017 - iopscience.iop.org
In this study, we investigate the use of imaging feature-based outcomes research ('radiomics')
combined with machine learning techniques to develop robust predictive models for the …

[HTML][HTML] Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system

…, A Ku, T Kalidindi, SG Lee, M Grkovski… - Nature …, 2021 - nature.com
Diseases are a manifestation of how thousands of proteins interact. In several diseases,
such as cancer and Alzheimer’s disease, proteome-wide disturbances in protein-protein …

Multiparametric imaging of tumor hypoxia and perfusion with 18F-fluoromisonidazole dynamic PET in head and neck cancer

M Grkovski, H Schöder, NY Lee, SD Carlin… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Tumor hypoxia and perfusion are independent prognostic indicators of patient outcome. We
developed the methodology for and investigated the utility of multiparametric imaging of …

Biodistribution and dosimetry of intraventricularly administered 124I-omburtamab in patients with metastatic leptomeningeal tumors

…, PB Zanzonico, K Kramer, M Grkovski… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Radiation dose estimations are key for optimizing therapies. We studied the role of 124 I-omburtamab
(8H9) given intraventricularly in assessing the distribution and radiation doses …

Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer

M Grkovski, NY Lee, H Schöder, SD Carlin… - European journal of …, 2017 - Springer
Purpose There is growing recognition that biologic features of the tumor microenvironment
affect the response to cancer therapies and the outcome of cancer patients. In head and neck …

[PDF][PDF] Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment

…, GJ Patti, MS Graham, A Mauguen, M Grkovski… - Med, 2022 - cell.com
Background Brain cancer incidence and mortality rates are greater in males. Understanding
the molecular mechanisms that underlie those sex differences could improve treatment …